Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Succinylcholine | The therapeutic efficacy of Succinylcholine can be increased when used in combination with Magnesium acetate. |
| Metocurine iodide | The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Magnesium acetate. |
| Gallamine triethiodide | The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Magnesium acetate. |
| Cisatracurium | The therapeutic efficacy of Cisatracurium can be increased when used in combination with Magnesium acetate. |
| Rocuronium | The therapeutic efficacy of Rocuronium can be increased when used in combination with Magnesium acetate. |
| Atracurium besylate | The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Magnesium acetate. |
| Doxacurium | The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium acetate. |
| Mivacurium | The therapeutic efficacy of Mivacurium can be increased when used in combination with Magnesium acetate. |
| Decamethonium | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium acetate. |
| Metocurine | The therapeutic efficacy of Metocurine can be increased when used in combination with Magnesium acetate. |
| Pancuronium | The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium acetate. |
| Pipecuronium | The therapeutic efficacy of Pipecuronium can be increased when used in combination with Magnesium acetate. |
| Vecuronium | The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium acetate. |
| Rapacuronium | The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium acetate. |
| Pyrantel | The therapeutic efficacy of Pyrantel can be increased when used in combination with Magnesium acetate. |
| Neosaxitoxin | The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Magnesium acetate. |
| Atracurium | The therapeutic efficacy of Atracurium can be increased when used in combination with Magnesium acetate. |
| Gallamine | The therapeutic efficacy of Gallamine can be increased when used in combination with Magnesium acetate. |
| Alcuronium | The therapeutic efficacy of Alcuronium can be increased when used in combination with Magnesium acetate. |
| Tubocurarine | The therapeutic efficacy of Tubocurarine can be increased when used in combination with Magnesium acetate. |
| Torasemide | The risk or severity of dehydration can be increased when Torasemide is combined with Magnesium acetate. |
| Methyclothiazide | The risk or severity of dehydration can be increased when Methyclothiazide is combined with Magnesium acetate. |
| Chlorthalidone | The risk or severity of dehydration can be increased when Chlorthalidone is combined with Magnesium acetate. |
| Ethoxzolamide | The risk or severity of dehydration can be increased when Ethoxzolamide is combined with Magnesium acetate. |
| Triamterene | The risk or severity of dehydration can be increased when Triamterene is combined with Magnesium acetate. |
| Spironolactone | The risk or severity of dehydration can be increased when Spironolactone is combined with Magnesium acetate. |
| Bendroflumethiazide | The risk or severity of dehydration can be increased when Bendroflumethiazide is combined with Magnesium acetate. |
| Metolazone | The risk or severity of dehydration can be increased when Metolazone is combined with Magnesium acetate. |
| Benzthiazide | The risk or severity of dehydration can be increased when Benzthiazide is combined with Magnesium acetate. |
| Amiloride | The risk or severity of dehydration can be increased when Amiloride is combined with Magnesium acetate. |
| Cyclothiazide | The risk or severity of dehydration can be increased when Cyclothiazide is combined with Magnesium acetate. |
| Furosemide | The risk or severity of dehydration can be increased when Furosemide is combined with Magnesium acetate. |
| Eplerenone | The risk or severity of dehydration can be increased when Eplerenone is combined with Magnesium acetate. |
| Methazolamide | The risk or severity of dehydration can be increased when Methazolamide is combined with Magnesium acetate. |
| Mannitol | The risk or severity of dehydration can be increased when Mannitol is combined with Magnesium acetate. |
| Hydroflumethiazide | The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Magnesium acetate. |
| Indapamide | The risk or severity of dehydration can be increased when Indapamide is combined with Magnesium acetate. |
| Acetazolamide | The risk or severity of dehydration can be increased when Acetazolamide is combined with Magnesium acetate. |
| Conivaptan | The risk or severity of dehydration can be increased when Conivaptan is combined with Magnesium acetate. |
| Chlorothiazide | The risk or severity of dehydration can be increased when Chlorothiazide is combined with Magnesium acetate. |
| Bumetanide | The risk or severity of dehydration can be increased when Bumetanide is combined with Magnesium acetate. |
| Etacrynic acid | The risk or severity of dehydration can be increased when Etacrynic acid is combined with Magnesium acetate. |
| Zonisamide | The risk or severity of dehydration can be increased when Zonisamide is combined with Magnesium acetate. |
| Hydrochlorothiazide | The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Magnesium acetate. |
| Trichlormethiazide | The risk or severity of dehydration can be increased when Trichlormethiazide is combined with Magnesium acetate. |
| Diclofenamide | The risk or severity of dehydration can be increased when Diclofenamide is combined with Magnesium acetate. |
| Polythiazide | The risk or severity of dehydration can be increased when Polythiazide is combined with Magnesium acetate. |
| Quinethazone | The risk or severity of dehydration can be increased when Quinethazone is combined with Magnesium acetate. |
| Drospirenone | The risk or severity of dehydration can be increased when Drospirenone is combined with Magnesium acetate. |
| Theobromine | The risk or severity of dehydration can be increased when Theobromine is combined with Magnesium acetate. |
| Piretanide | The risk or severity of dehydration can be increased when Piretanide is combined with Magnesium acetate. |
| Tienilic acid | The risk or severity of dehydration can be increased when Tienilic acid is combined with Magnesium acetate. |
| Ularitide | The risk or severity of dehydration can be increased when Ularitide is combined with Magnesium acetate. |
| Tolvaptan | The risk or severity of dehydration can be increased when Tolvaptan is combined with Magnesium acetate. |
| Indisulam | The risk or severity of dehydration can be increased when Indisulam is combined with Magnesium acetate. |
| Azosemide | The risk or severity of dehydration can be increased when Azosemide is combined with Magnesium acetate. |
| Canrenoic acid | The risk or severity of dehydration can be increased when Canrenoic acid is combined with Magnesium acetate. |
| Potassium citrate | The risk or severity of dehydration can be increased when Potassium citrate is combined with Magnesium acetate. |
| Efonidipine | The risk or severity of dehydration can be increased when Efonidipine is combined with Magnesium acetate. |
| Mersalyl | The risk or severity of dehydration can be increased when Mersalyl is combined with Magnesium acetate. |
| Isosorbide | The risk or severity of dehydration can be increased when Isosorbide is combined with Magnesium acetate. |
| Canrenone | The risk or severity of dehydration can be increased when Canrenone is combined with Magnesium acetate. |
| Rolofylline | The risk or severity of dehydration can be increased when Rolofylline is combined with Magnesium acetate. |
| Spiradoline | The risk or severity of dehydration can be increased when Spiradoline is combined with Magnesium acetate. |
| Cicletanine | The risk or severity of dehydration can be increased when Cicletanine is combined with Magnesium acetate. |
| Meticrane | The risk or severity of dehydration can be increased when Meticrane is combined with Magnesium acetate. |
| Mefruside | The risk or severity of dehydration can be increased when Mefruside is combined with Magnesium acetate. |
| Mebutizide | The risk or severity of dehydration can be increased when Mebutizide is combined with Magnesium acetate. |
| Cyclopenthiazide | The risk or severity of dehydration can be increased when Cyclopenthiazide is combined with Magnesium acetate. |
| Clorexolone | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium acetate. |
| Clofenamide | The risk or severity of dehydration can be increased when Clofenamide is combined with Magnesium acetate. |
| Fenquizone | The risk or severity of dehydration can be increased when Fenquizone is combined with Magnesium acetate. |
| Clopamide | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium acetate. |
| Muzolimine | The risk or severity of dehydration can be increased when Muzolimine is combined with Magnesium acetate. |
| Xipamide | The risk or severity of dehydration can be increased when Xipamide is combined with Magnesium acetate. |
| Epitizide | The risk or severity of dehydration can be increased when Epitizide is combined with Magnesium acetate. |
| Bromotheophylline | The risk or severity of dehydration can be increased when Bromotheophylline is combined with Magnesium acetate. |
| Potassium | The risk or severity of dehydration can be increased when Potassium is combined with Magnesium acetate. |
| Potassium cation | The risk or severity of dehydration can be increased when Potassium cation is combined with Magnesium acetate. |
| Buthiazide | The risk or severity of dehydration can be increased when Buthiazide is combined with Magnesium acetate. |
| Tripamide | The risk or severity of dehydration can be increased when Tripamide is combined with Magnesium acetate. |
| Isradipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Isradipine. |
| Diltiazem | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Diltiazem. |
| Trimethadione | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Trimethadione. |
| Amlodipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Amlodipine. |
| Nimodipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Nimodipine. |
| Nisoldipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Nisoldipine. |
| Lercanidipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Lercanidipine. |
| Cinnarizine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Cinnarizine. |
| Ethosuximide | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Ethosuximide. |
| Nicardipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Nicardipine. |
| Magnesium sulfate | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Magnesium sulfate. |
| Verapamil | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Verapamil. |
| Felodipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Felodipine. |
| Nitrendipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Nitrendipine. |
| Perhexiline | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Perhexiline. |
| Nifedipine | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Nifedipine. |
| Amiodarone | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Amiodarone. |
| Carvedilol | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Carvedilol. |
| Bepridil | The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Bepridil. |